Microbiol Spectr. 2023 Nov 15:e0207823. doi: 10.1128/spectrum.02078-23. Online ahead of print.
ABSTRACT
The World Health Organization estimated that 5-10 million people are infected with human T-cell leukemia virus type 1 (HTLV-1). This number is likely to be underestimated because reliable endemic data are available for only approximately 1.5 billion people worldwide. The point-of-care test is a powerful tool for the easy and quick detection of infections without the requirement for expensive instruments and laboratory equipment. Espline HTLV-I/II, a newly developed rapid immunochromatographic antibody test that was evaluated in this study, might significantly advance our understanding of the global epidemiology of HTLV-1 infection.
PMID:37966220 | DOI:10.1128/spectrum.02078-23
